Additionally, the percentages of CD4+IL-9+ T cells and serum IL-9 levels in eight untreated active SLE patients were decreased at 1, 2, and 3 weeks after treatment with methylprednisolone, suggesting an important role of IL-9 in the pathogenesis of SLE. Here, IL9 is linked to systemic lupus erythematosus.